AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Apellis Pharmaceuticals, Inc. Director's Dealing 2025

Jan 10, 2025

Director's Dealing

Opens in your device viewer

Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2025-01-08

Reporting Person: Walbert Keli (Director)